93 related articles for article (PubMed ID: 23559456)
1. Oseltamivir phosphate-amberlite(TM) IRP 64 ionic complex for taste masking: preparation and chemometric evaluation.
Siddiqui A; Shah RB; Khan MA
J Pharm Sci; 2013 Jun; 102(6):1800-1812. PubMed ID: 23559456
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo correlation of disintegration and bitter taste masking using orally disintegrating tablet containing ion exchange resin-drug complex.
Kim JI; Cho SM; Cui JH; Cao QR; Oh E; Lee BJ
Int J Pharm; 2013 Oct; 455(1-2):31-9. PubMed ID: 23933050
[TBL] [Abstract][Full Text] [Related]
3. Utilization of a modified special-cubic design and an electronic tongue for bitterness masking formulation optimization.
Li L; Naini V; Ahmed SU
J Pharm Sci; 2007 Oct; 96(10):2723-34. PubMed ID: 17506509
[TBL] [Abstract][Full Text] [Related]
4. Effect of drug-ion exchange resin complex in betahistine hydrochloride orodispersible film on sustained release, taste masking and hygroscopicity reduction.
Shang R; Liu C; Quan P; Zhao H; Fang L
Int J Pharm; 2018 Jul; 545(1-2):163-169. PubMed ID: 29729403
[TBL] [Abstract][Full Text] [Related]
5. Cholorpheniramine tannate complexes: physicochemical, chemometric, and taste masking evaluation.
Rahman Z; Zidan AS; Khan SR; Reddy IK; Khan MA
Int J Pharm; 2012 Oct; 436(1-2):582-92. PubMed ID: 22868234
[TBL] [Abstract][Full Text] [Related]
6. Complexation between risperidone and amberlite resin by various methods of preparation and binding study.
Shah RB; Tawakkul MA; Sayeed VA; Khan MA
Drug Dev Ind Pharm; 2009 Dec; 35(12):1409-18. PubMed ID: 19929200
[TBL] [Abstract][Full Text] [Related]
7. Development of a taste-masked oral suspension of clindamycin HCl using ion exchange resin Amberlite IRP 69 for use in pediatrics.
Alayoubi A; Daihom B; Adhikari H; Mishra S; Helms R; Almoazen H
Drug Dev Ind Pharm; 2016 Oct; 42(10):1579-89. PubMed ID: 26926148
[TBL] [Abstract][Full Text] [Related]
8. Complexation of risperidone with a taste-masking resin: novel application of near infra-red and chemical imaging to evaluate complexes.
Tawakkul MA; Shah RB; Zidan A; Sayeed VA; Khan MA
Pharm Dev Technol; 2009; 14(4):409-21. PubMed ID: 19630698
[TBL] [Abstract][Full Text] [Related]
9. Tannate complexes of antihistaminic drug: sustained release and taste masking approaches.
Rahman Z; Zidan AS; Berendt RT; Khan MA
Int J Pharm; 2012 Jan; 422(1-2):91-100. PubMed ID: 22037447
[TBL] [Abstract][Full Text] [Related]
10. Development of Child-Friendly Lisdexamfetamine Chewable Tablets Using Ion Exchange Resin as a Taste-Masking Carrier Based on the Concept of Quality by Design (QbD).
Zhu C; Chen J; Shi L; Liu Q; Liu C; Zhang F; Wu H
AAPS PharmSciTech; 2023 Jun; 24(5):132. PubMed ID: 37291437
[TBL] [Abstract][Full Text] [Related]
11. Deciphering molecular mechanics in the taste masking ability of Maltodextrin: Developing pediatric formulation of Oseltamivir for viral pandemia.
Kalra A; Bhat P; Kaur IP
Carbohydr Polym; 2021 May; 260():117703. PubMed ID: 33712119
[TBL] [Abstract][Full Text] [Related]
12. Assessment of taste masking of captopril by ion-exchange resins using electronic gustatory system.
Chikukwa MTR; Wesoly M; Korzeniowska AB; Ciosek-Skibinska P; Walker RB; Khamanga SMM
Pharm Dev Technol; 2020 Mar; 25(3):281-289. PubMed ID: 31680590
[TBL] [Abstract][Full Text] [Related]
13. Masking the taste of the conditioned taste aversion agent levamisole using an ion-exchange resin, for practical application in wildlife management.
Cotterill JV; Massei G; Cowan DP
Pest Manag Sci; 2006 Feb; 62(2):120-5. PubMed ID: 16217732
[TBL] [Abstract][Full Text] [Related]
14. Development and physicochemical characterization of clindamycin resinate for taste masking in pediatrics.
Daihom B; Alayoubi A; Ma D; Wang L; Mishra S; Helms R; Almoazen H
Drug Dev Ind Pharm; 2016 Oct; 42(10):1600-8. PubMed ID: 26928944
[TBL] [Abstract][Full Text] [Related]
15. Fabrication and evaluation of taste masked resinate of risperidone and its orally disintegrating tablets.
Shukla D; Chakraborty S; Singh S; Mishra B
Chem Pharm Bull (Tokyo); 2009 Apr; 57(4):337-45. PubMed ID: 19336927
[TBL] [Abstract][Full Text] [Related]
16. Formulation and development of taste masked fast-disintegrating tablets (FDTs) of Chlorpheniramine maleate using ion-exchange resins.
Yewale CP; Rathi MN; Kore GG; Jadhav GV; Wagh MP
Pharm Dev Technol; 2013; 18(2):367-76. PubMed ID: 22023351
[TBL] [Abstract][Full Text] [Related]
17. Preparation and evaluation of taste-masked dextromethorphan oral disintegrating tablet.
Samprasit W; Opanasopit P; Akkaramongkolporn P; Ngawhirunpat T; Wongsermsin K; Panomsuk S
Pharm Dev Technol; 2012; 17(3):315-20. PubMed ID: 21142821
[TBL] [Abstract][Full Text] [Related]
18. Taste masking of Etoricoxib by using ion-exchange resin.
Patra S; Samantaray R; Pattnaik S; Barik BB
Pharm Dev Technol; 2010; 15(5):511-7. PubMed ID: 19845450
[TBL] [Abstract][Full Text] [Related]
19. Formulation and biopharmaceutical evaluation of bitter taste masking microparticles containing azithromycin loaded in dispersible tablets.
Tung NT; Tran CS; Nguyen TL; Hoang T; Trinh TD; Nguyen TN
Eur J Pharm Biopharm; 2018 May; 126():187-200. PubMed ID: 28359878
[TBL] [Abstract][Full Text] [Related]
20. Preparation and Evaluation of Taste Masking Iron Suspension: Taking Advantage of Weak Cationic Exchange Resin.
Kouchak M; Ramezani Z; Bagheri F
AAPS PharmSciTech; 2018 Feb; 19(2):719-729. PubMed ID: 28971358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]